Angiotensin II receptor type 1 (AT1) signaling stimulates proliferation of VSMC and vascular fibrosis [75], while the AT1 receptor blocker Losartan has been shown to reduce experimental aneurysm formation in mouse models of Marfan's disease [76]. Here, AGTR1 is linked to aneurysm.